根據最新的財務報表(Form-10K),Virbac SA 的總資產為 $0,淨isProfitable}為 $0
VRBCF 的關鍵財務比率是什麼?
Virbac SA 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Virbac SA 的收入按細分市場或地理位置如何劃分?
Virbac SA 最大收入來源為 Farm Animals - Other Ruminants,在最近的收益報告中收入為 208,100,000。就地區而言,Europe (excluding France) 是 Virbac SA 的主要市場,收入為 326,742,000。
Virbac SA 是否盈利?
無,根據最新的財務報表,Virbac SA 的淨損失為 $0
Virbac SA 有負債嗎?
無,Virbac SA 的負債為 0
Virbac SA 的流通股有多少?
Virbac SA 的總流通股為 0
關鍵數據
前收市價
$383.25
開盤價
$383.25
當日範圍
$383.25 - $383.25
52週區間
$346 - $431.8
交易量
1
平均成交量
2
股息收益率
--
每股盈餘 (TTM)
20.48
市值
$3.2B
什麼是 Virbac SA?
Virbac SA engages in the manufacture and sale of veterinary medicines. The company is headquartered in Carros, Paca and currently employs 6,442 full-time employees. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. The company also offers food and electronic identification chips for pets.